Neuroprotective Effect of Astragaloside IV on Cerebral Ischemia/Reperfusion Injury Rats Through Sirt1/Mapt Pathway

Background: Ischemic stroke is a common disease with poor prognosis, which has become one of the leading causes of morbidity and mortality worldwide. Astragaloside IV (AS-IV) is the main bioactive ingredient of Astragali Radix (which has been used for ischemic stroke for thousands of years) and has...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Front Pharmacol
Glavni autori: Shi, Yi-Hua, Zhang, Xi-Le, Ying, Peng-Jie, Wu, Zi-Qian, Lin, Le-Le, Chen, Wei, Zheng, Guo-Qing, Zhu, Wen-Zong
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2021
Teme:
Pharmacology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8033022/
https://ncbi.nlm.nih.gov/pubmed/33841157
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.639898
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items